Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hitachi
Asia
AstraZeneca, Novartis, Clover and more—FiercePharmaAsia
Pulmicort sales in China slowed AZ down. Novartis set a CAR-T facility in Japan. China's Clover nabs about $260 million from CEPI for COVID-19 shot.
Angus Liu
Nov 6, 2020 9:48am
Minaris invests in new German, Japanese manufacturing facilities
Nov 3, 2020 12:30pm
Dengue vaccine, Pfizer and more—FiercePharmaAsia
Feb 1, 2019 10:50am
Hitachi gets EU cell manufacturing facilities
Jan 31, 2019 11:15am
FiercePharmaAsia—Takeda, WuXi AppTec and Aslan
Mar 30, 2018 10:25am
FiercePharmaAsia: Novartis, Astellas, Eli Lilly and more
Mar 3, 2017 8:06am
